FORMULATION AND EVALUATION OF ROXITHROMYCIN NANOSPONGE GEL FOR ANTIBACTERIAL ACTIVITY

Keywords

Abstract

References

1. [1]1. Krishnamoorthy K, Rajappan M. Nanosponges: a novel class of drug delivery system--review. J. Pharm. Pharm. Sci: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2012;15(1):103-11.
2. [2]2. Goel V, Nautiyal U, Raina D. Development and evaluation of nanosponge loaded hydrogel of Ceftriaxone for the treatment of anti-bacterial infections. Biomed Eng Commun. 2025;4(3):19.
3. [3]3. Alongi J, Poskovic M, Frache A, Trotta F. Role of β-cyclodextrin nanosponges in polypropylene photooxidation. Carbohydrate Polymers. 2011;86(1):127-35
4. [4]4. Patel B, Bagade O, Ramteke K, Patel R, Awsarkar V. An assessment on preparations, characterization, and poles apart appliances of nanosponge. Int. J. Pharm.Tech. Res. 2014;6(7):2092-101
5. [5]5. Trotta F, Zanetti M, Cavalli R. Cyclodextrin-based nanosponges as drug carriers. Beilstein J. Org. Chem. 2012;8(1):2091-9
6. [6]6. Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can. J. Infect. Dis. and Med. Microbiol. 2008;19(2):173-84.
7. [7]7. Bryskier A. Roxithromycin: review of its antimicrobial activity. The Journal of antimicrobial chemotherapy. 1998 Mar 1;41(suppl_2):1-21.
8. [8]8. Young RA, Gonzalez JP, Sorkin EM. Roxithromycin: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1989 Jan;37:8-41
9. [9]9. Hingmire LP, Deshmukh VN, Sakarkar DM. Development and evaluation of sustained release matrix Tablets using natural polymer as release modifier. 2008;1(3):193-6.
10. [10]10. Arun DK, Kishanta PK, Ranjita D. Murthy PN, Amithesh PK. Method development, validation and stability study of Repaglinide in bulk and pharmaceutical dosage form by spectro photometric method. IJBPR 2011: 2(1):7-10
11. [11]11. Sahu M, Bhowmick M, Rathi J. Preformulation screening of repaglinide for transdermal anti-diabetic therapy. J. Drug. Del. Ther. 2017;7(4):103-9
12. [12]12. Jain NA, Lohiya RT,Umekar MJ. Spectro photometric determination of naproxen and esomeprazole in a laboratory mixture by Simultaneous equation, absorption correction, absorption ratio and area curve methods.Int. J. Pharm. Sci. Res. 2011;2(5):130-4.
13. [13]13. Solunke RS, Borge UR, Murthy K, Deshmukh MT, Shete RV. Formulation and evaluation of gliclazide nanosponges. Int J Appl Pharm. 2019:181-9.
14. [14]14. Kasliwal RH,Thakre AR, Gholse YN. Nanosponges: a novel approach of drug delivery system. J. Med. Pharm. Allied. Sci. 2016;78(92):78.
15. [15]15. Sujitha YS, Muzib YI. Formulation and optimization of quercetin loaded nanosponges topical gel: Ex vivo, pharmacodynamic and pharmacokinetic studies. Int. J. Appl. Pharm. 2019;11(5):156-65.
16. [16]16. Mamtha DP, Viresh KC, Shabaraya AR. Nanosponges: an overview about the novel class of drug delivery system. World J Pharm Pharm Sci. 2021;10(6):1014-1027
17. [17]17. Sowmya shree, ShripathyD, Shabaraya AR. Nanosponges- a novel nanocarrier approach for targeted drug delivery a brief review. World J. Pharm. Pharm. Sci. 2021; 10(5): 417-35.
18. [18]18. Viresh KC, Gopika S, Shabaraya AR. Comparative characterization of gel loaded oxiconazole nitrate nanosponges for topical delivery. Eur J Pharm Med Res. 2023;10(1):364-372
19. [19]19. Solunke RS, BORGE UR, Murthy K, Deshmukh MT, SHETE RV. Formulation and evaluation of gliclazide nanosponges. Int. J. Appl. Pharm.. 2019;181-9.
20. [20]20. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi pharm. J. 2012;20(1):63-7.
21. [21]21. Manyam N, Budideti KK, Mogili S. Formulation and in-vitro evaluation of nanosponge loaded extended release tablets of trimethoprim. UPI J. Pharm. Med. Health Sci. 2018:78-86.
22. [22]22. Iriventi P, Gupta NV, Osmani RA, Balamuralidhara V. Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. DARU J. Pharm. Sci.. 2020;28(2):489-506
23. [23]23. Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta. Pol. Pharm. 2010;67(3):217-23.
24. [24]24. Yadav V,Jadhav P, Dombe S, Bodhe A, Salunkhe P. Formulation and evaluation of microsponge gel for topical delivery of antifungal drug. Int. J. Appl. Pharm. 2017;9:30-7.

Authors (2)